Alopecia associated with fluconazole therapy

Area of Science:

• Mycology
• Dermatology
• Pharmacology

Background:

• Fluconazole is a widely used antifungal medication.
• Alopecia is a potential side effect of various medications.
• The association between fluconazole and alopecia requires further investigation.

Purpose of the Study:

• To investigate the relationship between fluconazole use and the occurrence of reversible alopecia.
• To characterize the incidence and clinical presentation of fluconazole-induced alopecia.

Main Methods:

• A retrospective survey of patients treated with fluconazole by Mycoses Study Group (MSG) investigators.
• Analysis of data from 33 patients who developed alopecia during fluconazole therapy.
• Review of treatment protocols and patient outcomes.

Main Results:

• 33 patients experienced substantial alopecia while on fluconazole therapy.
• Alopecia occurred in patients with various deep and superficial mycoses.
• Higher doses (≥400 mg/d) for longer durations (≥2 months) were associated with increased risk.
• Hair loss resolved within 6 months of fluconazole discontinuation or dose reduction.

Conclusions:

• Alopecia is a common, albeit reversible, adverse effect of high-dose, long-term fluconazole treatment.
• Dose reduction or discontinuation of fluconazole leads to hair regrowth.
• Clinicians should monitor for alopecia in patients receiving prolonged fluconazole therapy.